Research into biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin antibiotics at common doses added to bone cement
Open Access
- 25 June 2020
- journal article
- research article
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 31 (2) , 328-334
Abstract
This study aims to investigate the biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin at commonly-used dose intervals added to polymethylmethacrylate (PMMA) in vitro. This prospective study was conducted between February 2016 and June 2016. Antibiotics were added to PMMA at doses frequently used in clinical practice. The antibiotic doses added were teicoplanin (2 g, 3 g, 4 g), gentamicin (0.5 g, 0.75 g, 1 g), daptomycin (0.5 g.) and vancomycin (2 g, 3 g, 4 g). Standard cement balls (10 mm) were created. Activated L929 mouse fibroblast cell culture was used for incubation. Agar diffusion, Cell Proliferation Kit II (XTT) test and electron microscope investigations were performed to examine biocompatibility and cytotoxicity. In the cytotoxicity test, teicoplanin at 4 g and daptomycin at 0.5 g doses were observed to cause reductions in viability percentages. The same doses caused 20% and 20-40% cell lysis indices during the agar diffusion test. On electron microscope images, cytotoxic effects in fibroblast cells and involvement with the surface of cement balls were observed. Gentamicin, vancomycin and teicoplanin were observed to be non-toxic and biocompatible at commonly-used dose intervals. Teicoplanin at 4 g and daptomycin at 0.5 g doses were identified to be cytotoxic and not biocompatible. When selecting antibiotics to be added to bone cement, care should be taken that the antibiotic is non-toxic and biocompatible.Keywords
This publication has 27 references indexed in Scilit:
- A Daptomycin-Xylitol-loaded Polymethylmethacrylate Bone Cement: How Much Xylitol Should Be Used?2013
- The effect of low dose teicoplanin-loaded acrylic bone cement on biocompatibility of bone cementActa Microbiologica Et Immunologica Hungarica, 2013
- Daptomycin: Local Application in Implant-Associated Infection and Complicated OsteomyelitisThe Scientific World Journal, 2012
- In Vitro Activities of Daptomycin-, Vancomycin-, and Teicoplanin-Loaded Polymethylmethacrylate against Methicillin-Susceptible, Methicillin-Resistant, and Vancomycin-Intermediate Strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2011
- Gentamicin negatively influenced osteogenic function in vitroInternational Orthopaedics, 2006
- Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitisJournal of Antimicrobial Chemotherapy, 2006
- Antibiotic-impregnated PMMA hip spacers: Current statusActa Orthopaedica, 2006
- Prosthetic-Joint InfectionsNew England Journal of Medicine, 2004
- Infection of orthopedic implants and the use of antibiotic-loaded bone cements: A reviewActa Orthopaedica, 2001
- Cell culture methods for testing BiocompatibilityClinical Materials, 1994